Journal article icon

Journal article

Imaging oligometastatic cancer before local treatment.

Abstract:

With the advent of novel treatment strategies to help widen the therapeutic window for patients with oligometastatic cancer, improved biomarkers are needed to reliably defi ne patients who can benefi t from these treatments. Multimodal imaging is one such option and should be optimised to comprehensively assess metastatic sites, disease burden, and response to neoadjuvant treatment in each disease setting. These features will probably remain important prognostic biomarkers, and are crucial in...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Department:
Oxford, MSD, Oncology
Role:
Author
More by this author
Department:
Oxford, MSD, Oncology
Role:
Author
More by this author
Department:
St Hughs College
Role:
Author
More by this author
Department:
Oxford, MSD, Oncology
Role:
Author
Publisher:
Elsevier Publisher's website
Journal:
Lancet Oncology Journal website
Volume:
17
Issue:
9
Pages:
e406-e414
Publication date:
2016-08-05
DOI:
EISSN:
1474-5488
ISSN:
1470-2045
Pubs id:
pubs:641850
URN:
uri:d24df7aa-f2f5-41fa-8cbd-d60ff87048e5
UUID:
uuid:d24df7aa-f2f5-41fa-8cbd-d60ff87048e5
Local pid:
pubs:641850
Language:
English
Keywords:

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP